معرفی
Hee-Hoon Kim is a Research Fellow in the Dixit Lab at Yale School of Medicine’s Department of Pathology. His research focuses on immunometabolic pathways, particularly in the context of inflammation and healthy aging. He investigates adipose tissue microenvironment changes during aging using novel models. Kim holds a PhD from KAIST (2022) and a postdoctoral position at KAIST (2023) before joining Yale.
His work spans liver disease mechanisms, including alcoholic steatosis, non-alcoholic fatty liver disease (NAFLD), and immunological interactions in fibrosis. Key research areas include glutamate signaling, exosome-mediated therapies, and the role of natural killer and macrophage cells in hepatic pathologies. Recent studies explore NAC and Panax ginseng’s therapeutic potential in NAFLD, as well as IL-11’s role in inflammation and longevity.
Kim’s publications emphasize translational approaches, combining molecular biology, systems immunology, and metabolic studies. Notable contributions include identifying GDF-15’s role in Kupffer cell apoptosis and mGluR5’s antifibrotic effects in liver fibrosis. His lab collaborations focus on co-culture systems and exosome-based drug delivery for liver injury mitigation.
